Perrigo (PRGO) Income from Continuing Operations (2012 - 2026)
Perrigo (PRGO) reported Income from Continuing Operations of 389800000.0 for Q1 2026, down 389900.0% year-over-year from N/an in Q1 2025, and up 72.44% quarter-over-quarter from 1414600000.0 in Q4 2025.
Perrigo (PRGO) Income from Continuing Operations (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Income from Continuing Operations data on file, last reported at 389800000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 389800000.0, down 389900.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1792200000.0 (down 988.16% YoY), and the FY2025 annual result was 1402300000.0, down 772.62% from the prior year.
- Income from Continuing Operations improved to 389800000.0 in Q1 2026 per PRGO's latest filing, from 1414600000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 15400000.0 in Q3 2023 and troughed at 1414600000.0 in Q4 2025.
- A 5-year average of 122841176.47 and a median of 12700000.0 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2026: Income from Continuing Operations surged 472.73% in 2024, then sank 389900.0% in 2026.
- A 5-year view of Income from Continuing Operations shows it stood at 12700000.0 in 2022, then tumbled by 118.11% to 27700000.0 in 2023, then tumbled by 49.82% to 41500000.0 in 2024, then plunged by 3308.67% to 1414600000.0 in 2025, then surged by 72.44% to 389800000.0 in 2026.
- Business Quant data shows PRGO's Income from Continuing Operations at 389800000.0 in Q1 2026, 1414600000.0 in Q4 2025, and 12700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Perrigo | 1.61 Bn | 1.25 Bn | 325.50 Mn | -389.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -389.80 Mn |
| Dec 31, 2025 | -1.41 Bn |
| Sep 27, 2025 | 12.70 Mn |
| Jun 28, 2025 | -500,000.00 |
| Mar 29, 2025 | 100,000.00 |
| Dec 31, 2024 | -41.50 Mn |
| Sep 28, 2024 | -17.60 Mn |
| Jun 29, 2024 | -105.70 Mn |
| Mar 30, 2024 | 4.10 Mn |
| Dec 31, 2023 | -27.70 Mn |
| Sep 30, 2023 | 15.40 Mn |
| Jul 1, 2023 | 8.90 Mn |
| Apr 1, 2023 | -1.10 Mn |
| Dec 31, 2022 | -12.70 Mn |
| Oct 1, 2022 | -52.10 Mn |
| Jul 2, 2022 | -64.90 Mn |
| Apr 2, 2022 | -1.30 Mn |
| Dec 31, 2021 | 32.10 Mn |
| Oct 2, 2021 | -53.90 Mn |
| Jul 3, 2021 | -111.90 Mn |